Two Sigma Securities’s Rosetta Genomics Ltd. ROSG Stock Holding History

Two Sigma Securities’s Portfolio ROSG Stock Details ROSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,698	Closed	-$9K	–	1242
2016 Q4	$9K	Sell	1,698 -230	-12%	-$1.76K	﹤0.01%	680
2016 Q3	$19K	Buy	+1,928	New	+$23.4K	0.01%	605

Other funds holding ROSG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HCM

Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Two Sigma Securities's ROSG Position: Q1 2017 in Review

Two Sigma Securities sold out of Rosetta Genomics Ltd. (ROSG) in Q1 2017, closing a stake of 1,698 shares — an estimated $9K sold.

Two Sigma Securities first reported a position in ROSG in Q3 2016 and held it in 2 quarters. The position peaked at $19K in Q3 2016. 9 funds tracked by Wall St. Rank hold ROSG as of Q1 2017.

Two Sigma Securities reported no remaining Rosetta Genomics Ltd. position as of Q1 2017 after selling out during the quarter.
Two Sigma Securities sold 1,698 Rosetta Genomics Ltd. shares in Q1 2017, an estimated $9K.
Two Sigma Securities first reported a position in Rosetta Genomics Ltd. in Q3 2016 and held it in 2 quarters.
Two Sigma Securities's Rosetta Genomics Ltd. position peaked at $19K in Q3 2016.
9 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q1 2017.

Based on Two Sigma Securities's 13F filing for Q1 2017, filed 15 May 2017.